CLINICAL_TRIALS
research
· 2026-03-27
Clinical Trial Update: Primary RPLND Versus Systemic Chemotherapy in Good-prognosis Metastatic Testicular Cancer [NA]
Summary
This clinical trial compares primary retroperitoneal lymph node dissection (RPLND) with systemic chemotherapy as initial treatment for good-prognosis metastatic…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sahlgrenska University Hospital | Conditions: Testicular Cancer, Seminoma | NA | Status: RECRUITING